Lead Product(s) : Allopurinol
Therapeutic Area : Rheumatology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Indoco Remedies Gains USFDA Final Approval for Allopurinol Tablets USP 200 mg
Details : Zyloprim-Generic (allopurinol) is a xanthine oxidase inhibitor. It is indicated for the treatment of primary or secondary gout, leukemia, lymphoma and solid tumor malignancies.
Product Name : Zyloprim-Generic
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 23, 2025
Lead Product(s) : Allopurinol
Therapeutic Area : Rheumatology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
